Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s ...

The UK biotech sector raised £3.5bn in 2024, marking a 94% increase from the previous year, according to the BioIndustry ...

SCIENCE: Trudeau Institute, Ampersand Biosciences producing tools for flu research with $1M grant SARANAC LAKE — Local research and biotechnology laboratories Trudeau Institute and Ampersand ...

(Reuters) -Drug developer Maze Therapeutics said on Monday it was targeting a valuation of as much as $728.1 million in its initial public offering in the United States. The South San Francisco, ...

The Amsterdam UMC has sued Ronald Plasterk and the biotech firm CureVac for failing to credit the hospital and its scientist, ...

Bispecific antibodies have altered the multiple myeloma (MM) treatment landscape, but some practices still lack enough familiarity with these therapeutics to deliver them in outpatient settings.

Press Release ImmunoMet Therapeutics, Inc., ("ImmunoMet", or the "Company"), a clinical stage biotechnology company committed to giving patients a novel approach to fight cancer, today provided a data ...

Unnatural Products, a Santa Cruz-based biotech company founded by UC Santa Cruz alumni Cameron Pye and Joshua Schwochert ...

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...

Shares of Dogwood Therapeutics Inc. rose over 18% in premarket trading Friday, following a jaw-dropping 370% surge in the ...